Technology Transfer Office

Transforming Our Discoveries Into Therapeutics
 

The Technology Transfer Office embodies the spirit of the National Jewish Health brand promise, Science Transforming Life®. We accelerate the development of basic scientific research towards clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization.

National Jewish Health currently has in its portfolio:

  • 176 active technologies developed from our research
  • 82 active US patents protecting these technologies
  • 50 percent of those active US patents are licensed to biotechnology companies for the development of therapeutics consistent with the spirit of the National Jewish Health brand promise, Science Transforming Life®.

Additionally, in the 10 years since the Technology Transfer Office was created, National Jewish Health has:

  • executed 191 license agreements, of which 110 are still active;
  • executed a total of 1432 material transfer agreements; and
  • helped create 8 start-up companies.

Technologies from National Jewish Health

To browse a list of the technologies ready for licensing or further development, select one of the following:


Featured Technology: Method for the Treatment of Cystic Fibrosis (SERCA2)

 

Staff

 

Emmanuel Hilaire, PhD
Manager
Phone: 303-398-1262
HilaireE@njhealth.org

Stephanie Piersma
Program Administrator
Phone: 303-398-1045
PiersmaS@njhealth.org


Contact Information
National Jewish Health
Technology Transfer Office
1400 Jackson St., M206
Denver, CO 80206
Fax: 303-270-2352

Appointments


1-800-222-5864

Faculty by Research


The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our A-Z directory of Faculty by Area of Research.